Hepatitis C Virus transmission after user of viraemic donors via heart or lung graft within in a controlled study (at a calculated risk due to preemptive treatment by a pangenotypic DAAs application) 2058 Read more about Hepatitis C Virus transmission after user of viraemic donors via heart or lung graft within in a controlled study (at a calculated risk due to preemptive treatment by a pangenotypic DAAs application)
